UNMC researchers team up with farmers to produce a therapeutic supplement.
Alpha synuclein is a presynaptic protein that, when misfolded, contributes to neuronal degeneration and the progression of ...
This milestone launches dapansutrile into Phase 2 clinical development for neurological conditions, expanding upon ongoing trials with dapansutrile in rheumatologic diseases (Phas ...
Falls and other non-dopaminergic symptoms in Parkinson’s disease remain a significant unmet need, with limited effective ...
Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked ...
New data show that blarcamesine completely rescued impaired motor functionBiomarker of nerve fiber density of dopaminergic nerve cells indicating ...
A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published ...
1don MSN
Cerebrospinal fluid biomarker improves diagnosis of Parkinson's disease and Lewy body dementia
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...
LOS ANGELES — Parkinson’s disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results